BTC Capital Management, Inc. - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BTC Capital Management, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2018$225,000
-17.3%
96,218
+4.0%
0.05%
+17.8%
Q1 2018$272,000
+7.9%
92,554
+1.0%
0.04%
+4.7%
Q4 2017$252,000–91,600–0.04%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders